Therapeutic Advances in Endocrinology and Metabolism (Aug 2024)

ANDROID and A/G ratio are correlated with sarcopenia among type 2 diabetes patients

  • Dongxiao Zhang,
  • Chen Li,
  • Wenchao Hu,
  • Lanjie He

DOI
https://doi.org/10.1177/20420188241269181
Journal volume & issue
Vol. 15

Abstract

Read online

Background: Fat distribution plays an important role in impaired glucose tolerance. Android adiposity (ANDROID) and gynoid adiposity (GYNOID) have been proven to be linked with insulin resistance. A higher risk of sarcopenia is associated with type 2 diabetes mellitus (T2DM). In this study, ANDROID, GYNOID, and ANDROID to GYNOID ratios (A/G ratios) were evaluated in T2DM patients to determine if they were associated with sarcopenia. Methods: We recruited 1086 T2DM patients, measured skeletal muscle index (SMI), ANDROID, GYNOID, and collected clinical data. Results: T2DM patients with 119 male subjects had sarcopenia (20.24%), and 72 female subjects had sarcopenia (16.51%). All patients with T2DM who had high ANDROID and A/G ratios were at a reduced risk of sarcopenia. The SMI showed a correlation with ANDROID and A/G ratios among subjects with T2DM. Conclusion: ANDROID and A/G ratios are inversely related to sarcopenia in T2DM patients.